Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...
According to the National Crime Report Bureau, over the last 10 years, the number of undertrial prisoners in jails has risen constantly, and around 77% of the population of total prisoners ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...
The Sterile Dry Powder API Market is witnessing robust growth driven by the increasing adoption of injectable drugs, expansion of biologics manufacturing, ...
This article seeks to understand major factors contributing to the gender gap as regards women education in Muslim societies.
AstraZeneca and Amgen's TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately ...
DelveInsight’s, “Mantle Cell Lymphoma- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback